Nancy Taylor Foundation For Chronic Diseases is located in Tulsa, OK. The organization was established in 2009. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Nancy Taylor Foundation For Chronic Diseases is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Nancy Taylor Foundation For Chronic Diseases generated $102.9k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (25.5%) each year. All expenses for the organization totaled $1.0m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Nancy Taylor Foundation For Chronic Diseases has awarded 48 individual grants totaling $5,834,194. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Edward L Taylor IV President/treasurer | 40 | $97,500 | |
Suzanne Taylor Vice President/secretary | 0 | $0 | |
Stephen J Taylor Director | 0 | $0 | |
Dawn Duca Director | 0 | $0 | |
Dr Harvey Ruben Director | 2.63 | $25,200 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $0 |
Interest on Savings | $0 |
Dividends & Interest | $40,149 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $62,749 |
Capital Gain Net Income | $62,749 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $102,898 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $122,700 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $1,716 |
Interest | $0 |
Taxes | $20,430 |
Depreciation | $0 |
Occupancy | $8,642 |
Travel, conferences, and meetings | $0 |
Printing and publications | $0 |
Other expenses | $11,105 |
Total operating and administrative expenses | $189,443 |
Contributions, gifts, grants paid | $852,000 |
Total expenses and disbursements | $1,041,443 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $46,979 |
Savings and temporary cash investments | $62,178 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $1,424,552 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Over the last fiscal year, Nancy Taylor Foundation For Chronic Diseases has awarded $852,000 in support to 6 organizations.
Grant Recipient | Amount |
---|---|
CHILDREN'S HOSPITAL OF PHILADELPHIA PURPOSE: MECHANISMS OF MMF/HO-1 REGULATION OF HYPERINFLAMMATION BY DR. BEHREN. | $108,000 |
UNIVERSITY OF PITTSBURGH PURPOSE: CELLULAR PHENOTYPE CONTRIBUTING TO IMMUNE DYSREGULATION IN LOCALIZED SCLERODERMA BY KATHRYN TOROK, M.D. | $100,000 |
NEMOURS FOUNDATIONALFRED I DUPONT H PURPOSE: PROGNOSTIC SYNOVIAL BIOMARKERS IN JUVENILE IDIOPATHIC ARTHRITIS BY ANNEMARIE BRESCIA, M.D. | $216,000 |
UNIVERSITY OF PITTSBURGH PURPOSE: TRANSLATIONAL EVALUATION OF THE PATHOGENICITY OF DNT CELLS IN RHEUMATIC DISEASES OF CHILDREN AND IN A MOUSE MODEL OF EARLY EARLY-ONSET SYNOVITIS BY ABBE N. DE VALLEJO, PH.D. | $212,000 |
YALE UNIVERSITY PURPOSE: TARGETED NEUROFEEDBACK: A NOVEL NONPHARMOLOGICAL TREATMENT FOR OCD BY DR. CHRIS PITTENGER | $108,000 |
YALE UNIVERSITY PURPOSE: NOVEL APPROACHES TO THE STUDY OF PAIN AND TARGETING OF CHRONIC PAIN BY DR. WAXMAN. | $108,000 |